Insider Trades26 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | TLSI | David Patience | Chief Financial Officer | 14,650 | $4.46 | $263.5M | -46.04% | +95.00% | $65.3K | -5.31% | — | Stalk |
| Jun 30, 2026 | Buy | TLSI | Richard Marshak | Chief Commercial Officer | 561 | $3.87 | $263.5M | -46.04% | +95.00% | $2.2K | +0.44% | — | Stalk |
| Jun 30, 2026 | Buy | TLSI | Mary T Szela | CEO and President | 3,990 | $3.87 | $263.5M | -46.04% | +95.00% | $15.4K | +0.37% | — | Stalk |
| May 15, 2026 | Sell | TLSI | Richard Marshak | Chief Commercial Officer | 543 | $2.67 | $263.5M | -46.04% | +95.00% | $1.4K | -0.43% | — | Stalk |
| May 15, 2026 | Buy | TLSI | David Patience | Chief Financial Officer | 7,100 | $2.43 | $263.5M | -46.04% | +95.00% | $17.3K | +2.64% | — | Stalk |
| May 15, 2026 | Buy | TLSI | Mary T Szela | CEO and President | 39,682 | $2.59 | $263.5M | -46.04% | +95.00% | $102.8K | +3.87% | — | Stalk |
| Mar 11, 2026 | Sell | TLSI | Bryan F. Cox | Chief of Research | 3,184 | $4.11 | $263.5M | -46.04% | +95.00% | $13.1K | -0.64% | — | Stalk |
| Mar 11, 2026 | Sell | TLSI | Jodi Devlin | Chief of Clinical Operations | 3,207 | $4.11 | $263.5M | -46.04% | +95.00% | $13.2K | -1.08% | — | Stalk |
| Mar 11, 2026 | Sell | TLSI | Richard Marshak | Chief Commercial Officer | 3,457 | $4.11 | $263.5M | -46.04% | +95.00% | $14.2K | -1.03% | — | Stalk |
| Mar 11, 2026 | Sell | TLSI | Jennifer Stevens | Chief Regulatory Officer | 3,530 | $4.11 | $263.5M | -46.04% | +95.00% | $14.5K | -0.93% | — | Stalk |
| Mar 11, 2026 | Sell | TLSI | Mary T Szela | CEO and President | 20,302 | $3.91 | $263.5M | -46.04% | +95.00% | $79.4K | -1.32% | — | Stalk |
| Feb 23, 2026 | Buy | TLSI | David Patience | Chief Financial Officer | 3,657 | $4.10 | $263.5M | -46.04% | +95.00% | $15.0K | +1.38% | — | Stalk |
| Feb 23, 2026 | Buy | TLSI | Mary T Szela | CEO and President | 30,487 | $4.10 | $263.5M | -46.04% | +95.00% | $125.0K | +4.10% | — | Stalk |
| May 19, 2025 | Buy | TLSI | James Emmett Young | Chief Financial Officer | 13,175 | $5.18 | $263.5M | -46.04% | +95.00% | $68.2K | +36.11% | — | Stalk |
| May 19, 2025 | Buy | TLSI | Bryan F. Cox | Chief of Research | 20,486 | $5.18 | $263.5M | -46.04% | +95.00% | $106.1K | +4.71% | — | Stalk |
| May 19, 2025 | Buy | TLSI | Richard Marshak | Chief Commercial Officer | 28,025 | $5.18 | $263.5M | -46.04% | +95.00% | $145.2K | +11.41% | — | Stalk |
| May 19, 2025 | Buy | TLSI | Jodi Devlin | Chief of Clinical Operations | 28,895 | $5.18 | $263.5M | -46.04% | +95.00% | $149.7K | +21.30% | — | Stalk |
| May 19, 2025 | Buy | TLSI | Jennifer Stevens | Chief Regulatory Officer | 37,159 | $5.18 | $263.5M | -46.04% | +95.00% | $192.5K | +13.69% | — | Stalk |
| Feb 5, 2025 | Buy | TLSI | James Emmett Young | Chief Financial Officer | 6,000 | $5.65 | $263.5M | -46.04% | +95.00% | $33.9K | +25.00% | — | Stalk |
| Jan 29, 2025 | Buy | TLSI | Mary T Szela | CEO AND PRESIDENT | 10,040 | $5.15 | $263.5M | -46.04% | +95.00% | $51.8K | +1.15% | — | Stalk |
| Jan 27, 2025 | Buy | TLSI | Mary T Szela | CEO AND PRESIDENT | 9,542 | $5.27 | $263.5M | -46.04% | +95.00% | $50.3K | +0.87% | — | Stalk |
| Jan 27, 2025 | Buy | TLSI | James Emmett Young | Chief Financial Officer | 24,000 | $5.40 | $263.5M | -46.04% | +95.00% | $129.6K | +32.00% | — | Stalk |
| Jan 27, 2025 | Buy | TLSI | Sean Murphy | Chief Manuf, Strategy&Bus Dev. | 30,000 | $5.24 | $263.5M | -46.04% | +95.00% | $157.2K | +7.05% | — | Stalk |
| Oct 5, 2024 | Sell | TLSI | Bryan F. Cox | CHIEF SCIENTIFIC & MANUFACT. | 314 | $4.44 | $263.5M | -46.04% | +95.00% | $1.4K | -0.36% | — | Stalk |
| Sep 12, 2024 | Buy | TLSI | Mary T Szela | CEO AND PRESIDENT | 14,815 | $5.09 | $263.5M | -46.04% | +95.00% | $75.4K | +1.32% | — | Stalk |
| Sep 10, 2024 | Buy | TLSI | Mary T Szela | CEO AND PRESIDENT | 5,000 | $4.97 | $263.5M | -46.04% | +95.00% | $24.9K | +1.37% | — | Stalk |